Raymond Debbane, 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 94,270,206 shares at $1.15 ($108.4M) on 2010-03-19, disclosed to the SEC on 2010-03-19.
Open-market purchase of $108.4M LXRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.15 | 760,870 | $875K | 0.8% |
| 2 | $1.15 | 5,190,848 | $6.0M | 5.5% |
| 3 | $1.15 | 29,021,739 | $33.4M | 30.8% |
| 4 | $1.15 | 59,296,749 | $68.2M | 62.9% |
| Total | $1.15 avg | 94,270,206 | $108.4M | 100% |
| Filing → |
| LXRX | BUY | 2026-02-23 | $220K | — | Filing → |
| LXRX | BUY | 2026-02-18 | $353K | — | Filing → |
| LXRX | BUY | 2023-10-12 | $2.2M | — | Filing → |